1990 - 1999 Publications

1990 - 1999

Ammari F, Davies MJ, Koppiker N, Gregory R, Burden AC. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 Diabetes Mellitus. Diabet Med 1999;16:142 146.

Davies MJ, Muehlbayer S, Garrick P, McNally PG. Potential impact of a change in the diagnostic criteria for diabetes mellitus on the prevalence of abnormal glucose tolerance in a local community at risk of diabetes: impact of new diagnostic criteria for diabetes mellitus. Diabet Med 1999;16:343-346.

Davies MJ, Ammari F, Sherriff C, Burden ML, Gujral J, Burden AC. Screening for Type 2 Diabetes Mellitus in the UK Indo-Asian population. Diabet Med 1999;16:131-137.

Davies MJ. New diagnostic criteria for diabetes - are they doing what they should? Lancet 1999;354:610 611.

Lawrence IG, Davies MJ. Diabetes and Myocardial Infarction: do we have time to wait? Pract Diab Int 1999;16:2:43-46.

Davies MJ. Is screening for Type 2 diabetes justified? Practitioner 1999;243:93-94.

Davies M. New diagnostic criteria for diabetes mellitus – prevalence is reduced using these criteria rather than 1985 WHO criteria. British Medical Journal Feb 1999. PMID 10094539

White SA, Koppiker NP, Burden AC, Davies MJ, Davies JE, Clayton HA, Swift SM, Hales CN. Insulin deficiency and increased intact and 32/33 split proinsulin secretion following human islet autotransplantation. Transplantation Proceedings 1998;30:627-628.

Davies MJ. A change in the diagnostic criteria for diabetes mellitus: what will the impact be? Pract Diab Int 1998;15;8:227-229.

Liddell WG, Davies MJ, Shore AC, Howe J, Tooke JE. Maximum vasodilatory reserve is negatively correlated with BMI and waist circumference in women with polycystic ovarian syndrome. Journal of Vascular Research 35:26-26 01 August 1998

Davies MJ, Burden AC, Burden ML. Screening for NIDDM: increasing evidence that it is necessary. Part 1: should it be done? Pract Diab Int 1997;14:162-164.

Davies MJ, Burden AC, Burden ML. Screening for NIDDM: increasing evidence that it is necessary. Part 2: How should it be done? Pract Diab Int 1997;14:189-191.

Davies MJ, Gray IP. Impaired glucose tolerance; detection and follow-up should aim to reduce excess morbidity and mortality. Br Med J 1996;312:7026:264-265.

Davies MJ. Pathogenesis of non-insulin-dependent diabetes (NIDDM) EASD 95 Congress Report 1996;6 10.

Davies MJ. Screening for Type 2 diabetes - the pros and cons. Reducing the Burden of Diabetes 1996;6:8 11.

Davies MJ. Impaired glucose tolerance - what is it and what should we do about it? Diabetes Debate 1997;2:1-2.

Davies MJ, Howlett TA. A survey of current methods used in the United Kingdom to assess pituitary function. J R Soc Med 1996;89(3):159-164.

Davies MJ, Grenfell A, Day JL. Clinical characteristics and follow-up of subjects with non-insulin-dependent diabetes mellitus diagnosed by screening. Pract Diab Int 1996;13:3:75-78.

Rayman G, Davies MJ. Diabetes (1) Screening in the Community. Bayer Diagnostic Education Services. Technical Information Bulletin 1995 No 9.

Goddard W, Youde J, Davies MJ, Rathbone BJ, McNally PG. Diabetic Gastroparesis: a new aid for management. Pract Diab Int 1995;12(6):281-282.

Davies MJ, Tack CJJ. Meeting Report, the 12th Anglo-Danish-Dutch Diabetes Meeting 1994. Diabet Med 1995;12:177-178

Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with Type 2 diabetes Mellitus. Diabet Med 1994;11:71-78.

Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus. Diabet Med 1994;11:293 298.

Davies MJ, Rayman G, Grenfell A, Gray IP, Day JL, Hales CN. Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 1994;11:432-436.

Davies MJ, Howlett TA. Imaging in Endocrinology: use of a potential methodology for audit consensus development. Clin Endo 1994;41:385-389.

Davies M, Day J. Screening for non-insulin dependent diabetes mellitus: how often should it be performed? J Med Screening 1994;1(2):78-81.

Davies MJ, Hall DR, Ross BA. Rare Tracheal Tumours: two case reports of primary neurogenic tumours occurring in the trachea. Resp Med 1993;87:145-146.

Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed Type 2 diabetes mellitus. Diabet Med 1993;10:305-312.

Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993; 10:313 320.

Professional Advisory Committee of the British Diabetic Association. Population Screening for Diabetes Mellitus. Diabet Med 1993;10:777-781.

Davies MJ, Day J. Screening for Type 2 Diabetes; can screening be worthwhile and cost-effective? Suppl to Hospital Update 1993, 13-15.

Davies MJ, Metcalfe J, Williams DDR, Day JL. Community screening for non-insulin-dependent diabetes mellitus (NIDDM) : a comparison of self-testing for post-prandial glycosuria. Q J Med 1993;86:677-684.

Davies M, Rayman G, Day J. Increased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations? Br Med J 1992;304:1610-11.

Davies MJ, Alban Davies H, Cook C, Day JL. Self testing for Diabetes Mellitus. Br Med J 1991;303:696-8.

Jayne DR, Davies MJ, Fox CJ, Black CM, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991;337(8750):1137-1139.

Davies MJ, Hall DR. Wegener’s granulomatosis presenting as pulmonary metastases: value of antineutrophil cytoplasmic antibodies in diagnosis. Resp Med 1990;84(4):339-34

Back to top

To main page

Share this page: